Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Aug 2–Aug 9, 2026)
Here’s what’s on the biotech calendar for August 2–August 9: 0 FDA decision dates, 2 trial catalysts, and 5 earnings reports from tracked companies.
🧪 Trial Catalysts & Milestones
- BIIB, 2026-08-06: A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years Old Registry
📊 Earnings This Week
- IBRX, 2026-08-03 (est. EPS -0.07)
- AXSM, 2026-08-03 (est. EPS -0.75)
- ARTV, 2026-08-04 (est. EPS -0.83)
- ARVN, 2026-08-04 (est. EPS -0.85)
- GILD, 2026-08-05 (est. EPS -7.37)
📡 Run-up Radar Highlights
Stocks entering the pre-catalyst window with the strongest setups (full radar is a Premium feature):
- CAPR: BLA in 20 days, score 85/100
- ACRV: Phase 1, Recruiting in 10 days, score 53/100
- CORT: Phase 2, Active Trial in 30 days, score 45/100
Track your tickers on the BioRadar dashboard →
This digest is for informational purposes only and is not investment advice. Always do your own research.